| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $907.1M | +38.2% |
| R&D Expense | $30.1M | +127.7% |
| SG&A Expense | $349.9M | +28.6% |
| Operating Income | -$1.22B | -499.9% |
| Pre-tax Income | -$1.37B | -321.9% |
| Income Tax | -$56.4M | -174.7% |
| Net Income | -$1.31B | -342.3% |
| EPS (Basic) | -$3.69 | -297.3% |
| EPS (Diluted) | -$3.69 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $547.1M | +39.7% |
| Current Assets | $664.3M | +41.2% |
| Total Assets | $7.29B | +7.1% |
| Current Liabilities | $521.9M | +448.2% |
| Long-term Debt | $3.60B | +47.1% |
| Stockholders' Equity | $3.47B | -15.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$802.7M | -18.6% |
| Capital Expenditures | $407.1M | +62.3% |
| Investing Cash Flow | -$669.9M | +79.3% |
| Financing Cash Flow | $1.63B | -58.8% |
| Free Cash Flow | -$1.21B | -30.4% |
| -314.5% |